Dipeptidyl peptidase IV inhibitor-associated bullous pemphigoid: a recently recognized autoimmune blistering disease with unique clinical, immunological and genetic characteristics
Author:
Open Access
- 2 January 2019
- journal article
- review article
- Published by Taylor & Francis in Immunological Medicine
- Vol. 42 (1) , 22-28
Abstract
Bullous pemphigoid (BP) is an organ-specific autoantibody-mediated autoimmune blistering skin disorder that tends to affect the elderly. Tense blister formation associated with itchy urticarial erythema is clinically observed in BP, and subepidermal blister formation with eosinophilic infiltration is a histopathological characteristic. BP autoantibodies target two hemidesmosomal components in basal keratinocytes: BP180 and BP230. Anti-BP180 autoantibodies play major roles in blister formation. Although the autoantibody-mediated pathomechanism of blister formation has been extensively studied, little is known about how and why immune tolerance to BP180 may be broken in certain elderly individuals. Recently, BP has been increasingly reported in diabetes mellites (DM) patients receiving dipeptidyl peptidase-IV inhibitors (DPP4is), which are widely used anti-DM drugs. Pharmacovigilance and cohort studies have revealed that DPP4is, especially vildagliptin, teneligliptin, and linagliptin, are a potential risk factor for BP onset. Interestingly, it has been revealed that Japanese DPP4i-BP tends to show a non-inflammatory phenotype, with less erythema than normal BP, and that DPP4i-BP autoantibodies target distinct epitopes on BP180. In addition, human leukocyte antigen-DQB1*03:01 was identified as the major haplotype in Japanese DPP4i-BP. This review summarizes the latest understanding of the pathogenesis of BP, with a special focus on the recently recognized DPP4i-BP.Keywords
This publication has 42 references indexed in Scilit:
- Pemphigoid diseasesThe Lancet, 2013
- Antibodies to Pathogenic Epitopes on Type XVII Collagen Cause Skin Fragility in a Complement-Dependent and -Independent MannerThe Journal of Immunology, 2012
- Dynamic Interactions of Epidermal Collagen XVII with the Extracellular MatrixThe American Journal of Pathology, 2011
- Plasmin Plays a Role in the In Vitro Generation of the Linear IgA Dermatosis Antigen LADB97Journal of Investigative Dermatology, 2009
- Secretome-Based Proteomic Profiling of Ras-Transformed MDCK Cells Reveals Extracellular Modulators of Epithelial-Mesenchymal TransitionJournal of Proteome Research, 2009
- Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell functionTrends in Immunology, 2008
- Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptorFrontiers in Bioscience-Landmark, 2008
- Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severityBritish Journal of Dermatology, 2005
- Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoidJournal of Dermatological Science, 2005
- Keratinocytes from Patients Lacking Collagen XVII Display a Migratory PhenotypeThe American Journal of Pathology, 2004